Medicare Enrolled

Dr. Michael Caire, MD

Gastroenterology · Bradenton, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
101 RIVERFRONT BLVD STE 700, Bradenton, FL 34205
9417482417
In practice since 2010 (15 years)
NPI: 1770802134 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Caire from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Caire? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Caire

Dr. Michael Caire is a gastroenterology in Bradenton, FL, with 15 years in practice. Based on federal Medicare data, Dr. Caire performed 2,055 Medicare services across 1,013 unique beneficiaries.

Between the years covered by Open Payments, Dr. Caire received a total of $5,677 from 40 pharmaceutical and/or device companies across 240 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Caire is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ Top 13% volume in FL$ $5,677 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,055
Medicare services
Top 13% in FL for gastroenterology
1,013
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~137 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Infliximab infusion (Remicade)910$26$76
Office visit, established patient (30-39 min)250$93$256
Upper GI endoscopy with biopsy189$64$282
New patient office visit (45-59 min)150$112$338
Removal of polyps or growths of large bowel using an endoscope with mechanical snare115$200$523
Initial hospital admission, high complexity108$140$399
Colonoscopy with biopsy99$95$410
Insertion of guide wire with dilation of esophagus using a flexible endoscope77$128$339
New patient office visit (30-44 min)31$65$227
Hospital follow-up visit, high complexity29$89$206
Initial hospital admission, moderate complexity20$103$273
Administration of chemotherapy into vein, 1 hour or less19$101$268
Administration of chemotherapy into vein, each additional hour18$22$58
Colorectal cancer screening; colonoscopy on individual at high risk15$186$379
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk13$187$380
Limited ultrasound scan of abdomen12$56$176
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.3% high complexity
17.8% medium
38.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,677
Total received (2018-2024)
Avg $811/year across 7 years
Top 31% in FL for gastroenterology
40
Companies
240
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,653 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,118
2023
$1,276
2022
$457
2021
$427
2020
$211
2019
$131
2018
$1,057

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Covidien LP
$724
ABBVIE INC.
$623
Janssen Biotech, Inc.
$477
AbbVie Inc.
$454
Takeda Pharmaceuticals U.S.A., Inc.
$351
QOL Medical, LLC
$348
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$333
Regeneron Healthcare Solutions, Inc.
$297
Celgene Corporation
$247
GENZYME CORPORATION
$132
Olympus America Inc.
$127
EVOKE PHARMA, INC.
$118
Axonics, Inc.
$106
Ethicon Inc.
$103
Intercept Pharmaceuticals, Inc.
$97
Palette Life Sciences, Inc.
$89
Lilly USA, LLC
$88
Madrigal Pharmaceuticals
$80
RedHill Biopharma Inc.
$79
AbbVie, Inc.
$72
INTERCEPT PHARMACEUTICALS, INC.
$72
Boston Scientific Corporation
$70
BOSTON SCIENTIFIC CORPORATION
$67
Fresenius Kabi USA, LLC
$45
IRONWOOD PHARMACEUTICALS, INC
$43
Phathom Pharmaceuticals, Inc.
$42
Gilead Sciences, Inc.
$41
Braintree Laboratories, Inc.
$40
Ironwood Pharmaceuticals, Inc
$39
Ardelyx, Inc.
$37
Merck Sharp & Dohme LLC
$37
NESTLE HEALTHCARE NUTRITION INC.
$29
Allergan Inc.
$27
Amgen Inc.
$24
Celltrion USA Inc.
$24
Nestle HealthCare Nutrition Inc.
$23
E.R. Squibb & Sons, L.L.C.
$21
Ferring Pharmaceuticals Inc.
$18
AIMMUNE THERAPEUTICS, INC.
$17
VIVUS LLC
$15
Top 3 companies account for 32.1% of total payments
Associated products mentioned in payments ›
AVSOLA · Amitiza · Axonics r-SNM System · Barrx · CREON · DIFICID · DUPIXENT · ENTYVIO · EVIS EXERA · EXALT · EXALT BX 2 · EndoArmor · Entyvio · GATTEX · GENERAL POLYPECTOMY · GIMOTI · General - Polypectomy · HUMIRA · Humira · IBSRELA · IDACIO · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · Mavyret · OCALIVA · OMVOH · ORISE · PANCREAZE · REBYOTA · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · SOLESTA · STELARA · SUCRAID · SUFLAVE · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · VIBERZI · VOQUEZNA · VOWST · WATCHMAN · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $276 per 100 Medicare services performed
Looking for a gastroenterology in Bradenton?
Compare gastroenterologys in the Bradenton area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
69
Per 100K population
16.6
County median income
$75,792
Nearest hospital
SUNCOAST BEHAVIORAL HEALTH CENTER
4.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Caire is a clinical cardiology specialist, with above-average Medicare volume (top 13% in FL), and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Caire experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Caire performed 910 infliximab infusion (remicade) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Caire receive payments from pharmaceutical companies?
Yes. Dr. Caire received a total of $5,677 from 40 companies across 240 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Caire's costs compare to other gastroenterologys in Bradenton?
Dr. Caire's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Caire) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →